Clinical Trial Update: Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer [Phase 2]

View source ↗

Summary

The document reports a Phase 2 clinical trial update evaluating preoperative chemoradiotherapy with capecitabine and irinotecan for rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Rectal Neoplasm, Neoadjuvant Therapy | Phase 2 | Status: UNKNOWN